Advertising in the Indian Journal of Dermatology Venereology and Leprology: Rates, Formats, and What Pharma Brands Need to Know

Most pharmaceutical and cosmetic dermatology brands that come to us asking about IJDVL magazine advertising have already spent months placing ads in general medical publications — and wondering why the needle isn't moving. The Indian Journal of Dermatology, Venereology and Leprology is a different category of media buy entirely; it is one of the few peer-reviewed journals in India where the reader is not just a doctor but a specialist who is actively looking for clinical and product information relevant to their daily practice. With a journal impact factor of 3.4 and indexing across MEDLINE, SCOPUS, and Science Citation Index Expanded, IJDVL carries a credibility weight that most healthcare advertising India placements simply cannot match.

At SmartAds, we have placed campaigns across dozens of medical journals over the years, and the conversation about IJDVL comes up more often now than it did even three years ago — partly because the dermatology and cosmetology market in India has grown at a pace that surprised even the most optimistic forecasters, and partly because brands are getting more sophisticated about where they want their name to appear.

What Is the Indian Journal of Dermatology, Venereology and Leprology?

The journal has been around long enough that most senior dermatologists in India grew up reading it during their residency, which gives it a kind of institutional authority that no amount of digital advertising can manufacture overnight. Published by Scientific Scholar on behalf of the Indian Association of Dermatologists, Venereologists and Leprologists — better known as IADVL — the Indian Journal of Dermatology, Venereology and Leprology is the official scientific publication of one of the largest dermatological associations in Asia. IADVL has a membership base that runs into tens of thousands of practising specialists, and the journal reaches a significant proportion of that membership as part of the subscription model built into IADVL membership.

What makes IJDVL particularly valuable from an advertising standpoint is its indexing footprint. Being listed in MEDLINE / Index Medicus, SCOPUS, EMBASE / Excerpta Medica, Science Citation Index Expanded, and accessible through databases like ProQuest, EBSCO, Google Scholar, and CrossRef means that the journal is not just read — it is cited, referenced, and returned to repeatedly by the very specialists you want your pharma brand or cosmetic dermatology product in front of. The editorial board approval process for content is rigorous, which is precisely why the readership trusts what appears between those covers, including the advertisements. As a bimonthly journal, IJDVL publishes six issues per year, which gives advertisers a structured calendar to plan multi-insertion campaigns around.

We always tell our clients that the credibility transfer from a MEDLINE-indexed, peer-reviewed journal to an advertised brand is real and measurable — not in the abstract brand-awareness sense, but in the very concrete sense that a dermatologist who reads a clinical paper in IJDVL and then sees your molecule's ad on the facing page is encountering your brand in a context of scientific trust. That is a media environment most general magazine advertising in India cannot replicate.

Why Should Pharma and Healthcare Brands Advertise in IJDVL?

Frankly speaking, the case for dermatology journal advertising in a publication like IJDVL comes down to one thing that media planners often struggle to put a number on: audience quality. The readership is not a broad demographic of general practitioners who may or may not encounter your therapeutic category; it is dermatologists, venereologists, leprologists, cosmetologists, trichologists, and increasingly, specialists in pediatric dermatology — all of whom are actively engaged with the clinical literature in their field. When a pharmaceutical advertising campaign is placed in IJDVL, the brand is speaking directly to the prescription decision-maker, which is a targeting precision that most mass media channels cannot approach even with the most sophisticated programmatic tools.

The FICCI-EY Media and Entertainment Report has consistently noted that healthcare advertising India is one of the fastest-growing advertising segments in the country, with prescription drug advertisement and OTC skincare both contributing significantly to that growth. Within that broader trend, specialist journal advertising — and medical journal advertising in IJDVL specifically — represents a relatively underpriced channel given the quality of the target audience it delivers. One pharmaceutical client we worked with, a mid-sized dermatology-focused company launching a new topical antifungal, had been allocating the bulk of their promotion budget to medical representative visits and CME sponsorships; when we shifted a portion of that spend into a four-insertion IJDVL campaign, the brand recall scores among dermatologists in the post-campaign survey moved in a way that surprised even their own medical affairs team.

On top of that, there is a longevity argument for print advertisement in a journal like IJDVL that rarely gets made explicitly: a journal issue sits in a clinic, a hospital library, or a specialist's reading room for months, sometimes years. The Drugs and Magic Remedies Act India and the broader regulatory framework around prescription drug advertisement mean that pharmaceutical advertising in India must be factual, accurate, and directed at professionals — and a peer-reviewed journal is one of the few environments where that kind of detailed, clinically substantive ad creative can be deployed without the constraints of a mass-media format.

What Are the IJDVL Magazine Advertising Rates and Ad Format Options?

This is the question we get asked most often, and it is also where a lot of brands get frustrated because the information is not always easy to find in one place. Based on our experience booking ads in IJDVL and working with platforms like The Media Ant which aggregate India magazine ad rates for medical publications, the advertising rates for IJDVL work out to something in the following range — though we always recommend confirming current rates directly with Scientific Scholar or through an accredited media agency before finalising a booking, since rates are reviewed periodically.

A full page ad in colour, which is the most commonly booked format by pharmaceutical advertising clients, is typically priced somewhere in the ballpark of ₹40,000 to ₹55,000 per insertion, which is a number that often surprises brand managers when they compare it to what they are paying for a half-page in a general interest magazine with a far less qualified readership. A half page ad in colour runs roughly in the ₹22,000 to ₹30,000 range per insertion, making it a viable entry point for smaller pharma brands or cosmetic dermatology brands that are testing the channel for the first time. The premium positions — inside front cover, inside back cover, and back cover — command a meaningful premium over the run-of-journal rate; the back cover, which is the highest-demand placement and the one that gets the most passive exposure, is typically priced somewhere between ₹70,000 and ₹90,000 per insertion, depending on the issue and any special issue premium that may apply.

What a lot of people miss is that IJDVL also offers black and white ad options at a lower rate, which can work well for text-heavy, clinically detailed advertisements that do not rely on colour photography or product imagery — a format that is actually quite common in leprosy journal India and venereology advertising where the creative is built around data tables and prescribing information rather than brand imagery. The multiple insertions discount structure is worth understanding early in the planning process; bookings across four or more issues typically attract a negotiated rate that can bring the effective cost per insertion down by somewhere between 10 and 20 percent, which makes the campaign ROI calculation considerably more attractive. At SmartAds, we always negotiate multi-issue packages on behalf of our clients rather than booking issue by issue, because the savings over a year-long campaign can be substantial.

Who Is the Target Audience of IJDVL?

The target audience of the Indian Journal of Dermatology, Venereology and Leprology is, in one sense, exactly what it says on the cover — but the full picture is more nuanced and more valuable than the name alone suggests. The primary readership is made up of practising dermatologists across India, ranging from consultants in large urban hospitals to independent practitioners in tier-two and tier-three cities, all of whom are IADVL members and receive the journal as part of their membership. Venereologists and leprologists form a significant secondary segment of the readership, which matters enormously for brands operating in the sexually transmitted diseases space or for NGOs and public health organisations with messaging around leprosy treatment and awareness — the Sexually Transmitted Diseases journal space in India is relatively sparse, and IJDVL fills part of that gap.

What is less obvious, but increasingly important, is that the readership has expanded to include cosmetologists, trichologists, and specialists in pediatric dermatology as those sub-specialties have grown in India. The cosmetic dermatology market in India has been growing at a compound rate that most industry observers peg in the double digits, and the practitioners driving that growth — the doctors recommending chemical peels, laser treatments, hair loss therapies, and prescription-grade skincare — are reading IJDVL. This makes the journal an increasingly relevant platform for cosmetic dermatology brands that sit in the grey zone between pharmaceutical advertising and consumer beauty, particularly for products that require a doctor's recommendation even if they are not strictly prescription-only.

Medical colleges India represent another important segment of the readership — residents, postgraduate students, and faculty in dermatology departments across the country use IJDVL as a core academic reference, which means that brand visibility in the journal reaches the next generation of prescribers at the exact moment when their prescribing habits are being formed. Our experience shows that this audience segment is particularly valuable for brands in the early stages of building awareness among specialists, since the recall and association built during residency tends to persist well into independent practice.

What Is the Circulation and Readership Reach of IJDVL?

Circulation and readership are two different numbers, and the distinction matters more in medical journal advertising than it does in most other media categories. The circulation of IJDVL — meaning the number of physical copies distributed per issue — is tied primarily to the IADVL membership base, which has grown steadily over the years and is now estimated to be in the range of several thousand active members across India. As a bimonthly journal, each of the six annual issues reaches this membership directly, which means the circulation is consistent and predictable in a way that consumer magazine circulation, which fluctuates with newsstand sales, is not.

The readership figure — meaning the total number of individuals who read each copy, accounting for pass-along readership in clinic waiting rooms, hospital libraries, and departmental reading rooms — is meaningfully higher than the raw circulation number, as is typical for professional journals. On top of that, IJDVL's status as an open access journal means that the digital readership, which is accessed through the journal's website at ijdvl.com and through databases like PubMed, SCOPUS, and EBSCO, adds a substantial layer of reach beyond the print edition. The journal's presence on Google Scholar and CrossRef means that individual articles — and by extension, the ads placed in the same issues — are accessed by an international audience of researchers and clinicians, not just Indian practitioners.

The Media Ant, which is one of the platforms through which IJDVL magazine advertising can be booked, provides some publicly available reach data that gives advertisers a useful benchmark; the numbers suggest that the combined print and digital readership of IJDVL places it among the top-tier specialist medical journals in India by audience quality, even if its raw circulation figures are smaller than general medical publications. What we tell our clients is that in niche medical audience advertising, the cost per qualified reader is the metric that matters — and on that measure, IJDVL compares very favourably to broader medical media.

How Do You Book an Advertisement in the Indian Journal of Dermatology Venereology and Leprology?

The ad booking process for IJDVL is more straightforward than many first-time advertisers expect, though there are a few procedural steps that are worth understanding before you begin. The most direct route is to contact Scientific Scholar, the publisher, directly through the journal's official website, where advertising enquiries can be submitted; the publisher's team will provide a current rate card, confirm available placements in upcoming issues, and walk you through the material submission requirements. Alternatively, the advertise online booking route through platforms like The Media Ant allows brands to check availability, compare India magazine ad rates across multiple publications, and initiate a booking through a standardised digital workflow — which can be faster for brands that are managing multiple journal placements simultaneously.

The step-by-step process, as we have navigated it for clients, typically works as follows: the advertiser or their agency submits a booking request specifying the desired issue, placement position, and ad format; the publisher confirms availability and issues a booking confirmation along with the material specifications; the advertiser submits print-ready artwork by the material deadline, which is typically somewhere between three and four weeks before the issue's publication date; and the publisher's production team reviews the creative for compliance with editorial board approval requirements before the ad goes to press. For pharmaceutical advertising clients, this review step is important — the editorial team will check that the ad content complies with the Drugs and Magic Remedies Act India, the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), and the broader WHO ethical advertising standards that govern prescription drug advertisement in medical journals.

At SmartAds, we manage the entire ad booking workflow on behalf of our clients — from rate negotiation and placement selection through to artwork coordination and compliance review — which removes the friction that often causes campaigns to miss issue deadlines. We have found that first-time advertisers in IJDVL frequently underestimate the lead time required for the compliance review of pharmaceutical advertising creative, particularly for prescription drug advertisement that references clinical data or comparative efficacy claims; building an extra week into the production timeline is a discipline we enforce on every campaign.

What Are the Print and Online Advertising Options Available in IJDVL?

IJDVL offers advertising across both its print edition and its digital presence, which is a combination that gives brands more flexibility than a purely print-based journal would allow. The print advertisement options are the more established channel and include the full range of standard journal ad formats — full page, half page, back cover, inside front cover, and inside back cover — all of which are available in colour or black and white. The print edition is the primary vehicle for pharmaceutical advertising in IJDVL, given that the print readership is the core IADVL membership base and the physical journal is what circulates through clinics, hospitals, and academic departments.

The website advertising options at ijdvl.com are a growing part of the media mix for brands that want to extend their reach into the journal's digital readership. Banner advertisement placements on the journal website allow brands to maintain visibility with the online audience, which includes international readers accessing the open access journal content through PubMed, SCOPUS, and EMBASE. The CPM for website advertising in a niche medical audience context like IJDVL works out to a figure that is considerably higher than general display advertising — which is expected, given the audience quality — but the absolute cost of a digital campaign on a specialist journal website is typically quite modest in terms of total spend, making it a sensible complement to a print campaign rather than a standalone channel.

There is also the question of advertorial content, which some brands explore as a way of presenting more detailed clinical or educational information than a standard display ad allows. IJDVL's editorial board approval process for advertorial content is more rigorous than for standard display advertising, and the distinction between editorial and commercial content must be clearly maintained; but for brands with a genuine clinical story to tell — a new formulation, a long-term safety study, a real-world evidence programme — an advertorial placed in a peer-reviewed journal carries a credibility weight that a standard print advertisement cannot replicate. We have navigated this process for a couple of clients and the key is to engage with the editorial team early and ensure that the content meets the journal's standards for scientific accuracy.

Ad Placement Options: Full Page, Back Cover, Inside Cover, and More

The hierarchy of ad placement in IJDVL follows the logic of any print publication, but the specific dynamics of how dermatologists and specialists read a journal mean that some positions perform differently than they would in a consumer magazine. The back cover is universally the most sought-after position — it is the placement that gets seen every time the journal is picked up, set down, or passed between colleagues, which means the frequency of exposure per copy is significantly higher than any inside placement. The back cover rate reflects this demand, and in our experience, it is the position that sells out earliest for high-demand issues like the annual conference issue or any supplement issue tied to a major IADVL event.

The inside front cover is the second most premium position, and it benefits from being the first thing a reader encounters after opening the journal — a position that captures attention before the reader has settled into the editorial content. The inside back cover, by contrast, captures the reader at the moment of closing the journal, which creates a different kind of impression; it is a position we often recommend to clients who want a strong closing brand statement rather than an opening one. Run-of-journal full page ad placements and half page ad placements are distributed through the body of the journal and are less predictable in terms of exact position, though advertisers can sometimes request placement adjacent to specific editorial sections — a request that is more likely to be accommodated when the booking is made well in advance.

The colour vs black and white ad decision is worth thinking through carefully in the context of IJDVL's readership. Most pharmaceutical advertising in the journal uses full colour, which is the standard for product brand advertising and molecule launches; but for some categories — particularly for brands in the leprosy journal India space or for public health messaging — a well-designed black and white print advertisement can actually stand out more effectively against a field of colour ads than another colour execution would. We have seen this work particularly well for text-heavy ads that lead with clinical data rather than brand imagery.

What Are the Creative Specifications for IJDVL Magazine Ads?

Getting the artwork right for a print advertisement in IJDVL is one of those areas where small errors cause large problems, because a file submitted at the wrong resolution or in the wrong colour mode will either be rejected by the production team or will print poorly — neither of which is an outcome any advertiser wants after spending on a premium placement. The standard requirements for IJDVL print ads follow the conventions of professional print publishing: artwork should be submitted in CMYK colour mode rather than RGB, since the journal is printed using a four-colour offset process and RGB files will produce colour shifts when converted at the printer's end. Resolution should be a minimum of 300 DPI at the final print size, which is the industry standard for commercial print reproduction and ensures that photography, product imagery, and fine text all reproduce cleanly.

File formats accepted for print-ready artwork typically include high-resolution PDF (PDF/X-1a or PDF/X-4 are the preferred standards for print production), TIFF, and in some cases EPS for vector-based designs; JPEG files are generally not recommended for print submission because the compression artefacts become visible at print resolution. The trim size for a full page ad in IJDVL follows the journal's page dimensions, which are in the A4 range — advertisers should request the exact trim, bleed, and live area specifications from the publisher or from their media agency at the time of booking, since these dimensions need to be confirmed for each publication rather than assumed. Bleed artwork — meaning designs that extend to the edge of the page — requires an additional bleed margin, typically 3mm on all sides, beyond the trim dimensions.

For digital banner advertisement placements on the IJDVL website, the specifications are different: files are typically submitted as JPEG or PNG at screen resolution (72 DPI), in RGB colour mode, with file sizes kept below the publisher's specified maximum to ensure fast page loading. The dimensions for website banner placements vary by position — leaderboard, sidebar, and interstitial formats each have standard IAB dimensions — and these should be confirmed with the publisher's digital team at the time of booking. At SmartAds, we handle all artwork preparation and technical compliance checks as part of our campaign management service, which means our clients never have to worry about a last-minute rejection due to a file format issue.

Does IJDVL Follow Ethical Standards for Medical Journal Advertising?

This is a question that every responsible pharmaceutical advertising client should be asking before placing any ad in any medical journal, and the answer in IJDVL's case reflects the journal's standing as a serious academic publication. The Indian Journal of Dermatology, Venereology and Leprology operates within the framework of the WHO ethical advertising standards — specifically the World Health Organization's Ethical Criteria for Medicinal Drug Promotion — which set out the principles that should govern the promotion of pharmaceutical products to healthcare professionals. These criteria require that advertising content be accurate, balanced, and capable of being substantiated; that claims be consistent with the approved prescribing information; and that the promotional nature of the content be clearly identified as distinct from editorial content.

In the Indian regulatory context, pharmaceutical advertising in medical journals is also governed by the Drugs and Magic Remedies Act India, which prohibits certain categories of claims for medicinal products, and by the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), which is the industry's self-regulatory framework for prescription drug advertisement. The IFPMA code — the International Federation of Pharmaceutical Manufacturers and Associations' code of pharmaceutical marketing practices — provides an additional international benchmark that multinational pharma brands operating in India are expected to adhere to. IJDVL's editorial board approval process for advertising content is designed to ensure that ads placed in the journal meet these standards; submissions that contain unsubstantiated efficacy claims, misleading comparative statements, or content that violates the Drugs and Magic Remedies Act India will be returned for revision before publication.

What we tell our pharmaceutical advertising clients is that this compliance framework, which might seem like an obstacle, is actually one of the reasons why advertising in IJDVL is valuable. The fact that the journal's editorial board approval process screens out non-compliant advertising means that the ads which do appear in the journal carry an implicit endorsement of accuracy and professionalism — and dermatologists, who are sophisticated readers of both clinical literature and promotional material, notice and respond to that. A brand that appears in IJDVL has, in effect, passed a credibility test that not every publication requires.

How Does IJDVL Compare to Other Dermatology Journal Advertising Options in India?

The honest answer is that IJDVL occupies a position at the top of the hierarchy for dermatology journal advertising in India, and the comparison with other options is instructive for any brand trying to allocate a specialist journal advertising budget. The journal's combination of IADVL affiliation, MEDLINE indexing, SCOPUS indexing, Science Citation Index Expanded listing, and a journal impact factor of 3.4 places it ahead of most other Indian dermatology publications on the metrics that matter to both readers and advertisers. For comparison, the Journal of American Academy of Dermatology (JAAD) is the international benchmark for dermatology journal advertising globally, but its readership is predominantly North American and its advertising rates are considerably higher — making IJDVL the natural choice for brands focused on the Indian market.

Within India, there are other dermatology-focused publications and general medical journals that carry dermatology content, but few match IJDVL's combination of audience specificity, academic credibility, and the direct pipeline to the IADVL membership base. Some brands choose to advertise across multiple journals simultaneously — a strategy that makes sense when the campaign objective is broad awareness across the dermatology specialist community — and in those cases, IJDVL is almost always the anchor placement, with other journals adding incremental reach. The Media Ant's platform allows advertisers to compare India magazine ad rates across multiple medical publications, which can be a useful starting point for building a multi-journal media plan.

One automotive brand we worked with — and yes, this was a healthcare-adjacent campaign for a brand that had a dermatology wellness product line rather than a pharma molecule — found that combining an IJDVL full page ad campaign with targeted digital advertising on dermatology professional networks produced a synergy effect that neither channel delivered independently. The IJDVL print advertisement built the credibility and professional context; the digital retargeting reinforced the message with the same audience online. The campaign ROI, measured against the brand's own prescription tracking data, showed a meaningful uplift in recommendations among dermatologists who had been exposed to both channels — which is a result we have seen replicated across several similar campaigns since.

Frequently Asked Questions About IJDVL Magazine Advertising

Q: What are the advertising rates for the Indian Journal of Dermatology Venereology and Leprology (IJDVL)?

The advertising rates for IJDVL vary by placement position and colour specification, and they are subject to periodic revision by Scientific Scholar, the publisher. Based on our current market knowledge and bookings facilitated through platforms including The Media Ant, a full page ad in colour is typically priced somewhere in the range of ₹40,000 to ₹55,000 per insertion; a half page ad in colour runs roughly ₹22,000 to ₹30,000; and premium positions like the back cover are priced somewhere in the ₹70,000 to ₹90,000 range per insertion, which reflects the significantly higher exposure frequency that the back cover position delivers. Black and white ad rates are lower across all formats, and multiple insertions discount arrangements — typically available for bookings of four or more issues — can bring the effective rate down by somewhere between 10 and 20 percent. We always recommend confirming the current rate card directly with the publisher or through an accredited media agency before finalising a budget, since rates are updated and the figures above should be treated as indicative rather than definitive.

Q: How can I book an advertisement in the IJDVL magazine?

Ad booking for IJDVL can be done through two primary routes: directly with Scientific Scholar through the journal's official website, or through a media booking platform like The Media Ant which handles advertise online booking for a range of Indian medical journals. The direct route gives you the most flexibility for negotiating placement and multi-issue packages, while the platform route is faster and more standardised for straightforward single-issue bookings. Working through an integrated media agency like SmartAds gives you the advantage of consolidated booking, rate negotiation, and artwork compliance management — all of which are particularly valuable for pharmaceutical advertising clients who need to navigate the editorial board approval process for prescription drug advertisement content.

Q: What ad formats and placements are available in IJDVL (full page, half page, back cover)?

IJDVL offers a full range of standard print advertisement formats: full page ad (available in colour or black and white), half page ad (horizontal or vertical orientation, colour or black and white), inside front cover (colour, premium position), inside back cover (colour, premium position), and back cover (colour, the highest-demand placement in the journal). Run-of-journal placements are distributed through the body of the journal and are available at the standard rate, while the cover positions command a premium that reflects their superior exposure. Website advertising banner placements on ijdvl.com are also available for brands that want to extend their campaign into the digital readership of the open access journal, and advertorial formats can be arranged subject to editorial board approval.

Q: Who is the target audience that reads IJDVL?

The target audience of IJDVL is the specialist dermatology community in India — primarily dermatologists, venereologists, and leprologists who are members of IADVL, along with cosmetologists, trichologists, specialists in pediatric dermatology, and postgraduate students and faculty in dermatology departments at medical colleges India. The readership also includes an international audience of researchers and clinicians who access the journal through its open access digital platform and through databases like MEDLINE, SCOPUS, and EMBASE. For pharmaceutical advertising and cosmetic dermatology brands, this is a niche medical audience of exceptionally high quality — these are the prescription decision-makers and product recommenders whose awareness and preference directly influence patient treatment choices.

Q: What is the circulation and readership of the Indian Journal of Dermatology Venereology and Leprology?

The print circulation of IJDVL is tied to the IADVL membership base, which runs into several thousand active specialist members across India; as a bimonthly journal, each of the six annual issues reaches this membership directly. The total readership — accounting for pass-along readership in clinical and academic settings — is meaningfully higher than the raw circulation figure. On top of that, the open access journal digital readership through ijdvl.com and academic databases adds a substantial additional layer of reach, making the combined print and digital audience significantly larger than the print circulation figure alone would suggest. The Media Ant's published data on IJDVL reach provides a useful public benchmark for advertisers doing initial planning.

Q: Does IJDVL offer online or digital advertising in addition to print ads?

Yes — IJDVL offers website advertising placements on ijdvl.com in addition to its print advertisement formats. Banner advertisement positions on the journal website allow brands to reach the digital readership of the open access journal, which includes both Indian and international specialists accessing content through PubMed, SCOPUS, and direct website visits. The digital advertising options are typically sold separately from the print placements, though some publishers offer combined print-plus-digital packages that can improve the overall campaign ROI by ensuring consistent brand visibility across both the physical and digital touchpoints of the journal. Advertorial content is also available subject to editorial board approval, which is a format that works particularly well for brands with detailed clinical or educational messaging.

Q: What are the creative specifications and file format requirements for IJDVL magazine ads?

Print advertisement artwork for IJDVL should be submitted in CMYK colour mode at a minimum resolution of 300 DPI at the final print size; preferred file formats are high-resolution PDF (PDF/X-1a or PDF/X-4), TIFF, or EPS for vector artwork. Bleed artwork requires an additional 3mm bleed margin beyond the trim dimensions on all sides. The exact trim size, live area, and bleed dimensions for each ad format should be confirmed with the publisher at the time of booking, since these are specific to IJDVL's page dimensions. For digital banner advertisement on ijdvl.com, artwork should be in RGB colour mode at screen resolution (72 DPI) in JPEG or PNG format, with dimensions conforming to standard IAB banner sizes as specified by the publisher's digital team.

Q: How far in advance do I need to submit ad material for IJDVL?

The material submission deadline for IJDVL is typically somewhere between three and four weeks before the issue's publication date, though this can vary slightly depending on the issue and any special issue or supplement issue schedule. For pharmaceutical advertising clients whose creative must go through the editorial board approval process for compliance review, we recommend building an additional week into the production timeline — so effectively, aiming to have final artwork ready five weeks before the target issue date. Missing the material deadline means the booking rolls to the next issue, which disrupts campaign timing; at SmartAds, we build deadline tracking into our campaign management workflow to ensure this never happens.

Q: Are there discounts for multiple insertions or long-term advertising in IJDVL?

Multiple insertions discount arrangements are available for IJDVL and are typically negotiated directly with the publisher or through a media agency. Bookings covering four or more issues in a calendar year generally attract a discount in the range of 10 to 20 percent on the standard rate card, which makes the campaign ROI calculation for a sustained brand visibility programme considerably more attractive than a series of single-issue bookings at full rate. Bulk subscription advertising bundles — where advertising is combined with sponsored journal subscriptions to specific institutions or medical colleges India — are another option that some pharmaceutical advertising clients explore, and these can be negotiated as part of a broader IADVL partnership arrangement.

Q: What ethical guidelines govern pharmaceutical advertising in IJDVL?

Pharmaceutical advertising in IJDVL is governed by a layered framework of regulations and codes: the WHO ethical advertising standards (Ethical Criteria for Medicinal Drug Promotion), the Drugs and Magic Remedies Act India, the Uniform Code of Pharmaceutical Marketing Practices (UCPMP), and the IFPMA code for international pharmaceutical manufacturers. All advertising content is subject to editorial board approval before publication, and ads that contain unsubstantiated claims, misleading comparative statements, or content that violates the Drugs and Magic Remedies Act India will be returned for revision. This compliance framework is a feature, not a bug — it is one of the reasons why advertising in a peer-reviewed journal like IJDVL carries credibility with the specialist readership.

Q: Is advertising in IJDVL effective for reaching dermatologists and skin care brands in India?

In our experience, IJDVL magazine advertising is one of the most cost-effective channels available for reaching practising dermatologists in India, particularly when the campaign objective involves building clinical credibility and prescription intent rather than broad consumer awareness. The combination of IADVL affiliation, MEDLINE indexing, SCOPUS indexing, and a journal impact factor of 3.4 means that the journal is read with a level of attention and professional engagement that most advertising channels cannot match. A retail client in the cosmetic dermatology space that we worked with ran a six-issue campaign in IJDVL alongside a digital campaign targeting dermatology professionals, and the post-campaign research showed that brand awareness among dermatologists in the target cities had moved by a margin that their management team had not expected from a journal-only media buy.

Q: How does IJDVL's advertising reach compare to other medical journals in India?

IJDVL sits at the top of the specialist dermatology journal advertising hierarchy in India by virtue of its IADVL affiliation, its indexing footprint across MEDLINE, SCOPUS, EMBASE, and Science Citation Index Expanded, and its journal impact factor of 3.4 — which compares favourably to most other Indian specialist medical journals. For brands that need to reach dermatologists, venereologists, leprologists, cosmetologists, and trichologists specifically, no other Indian journal delivers the same combination of audience specificity and academic credibility. General medical journals reach a broader audience but a less targeted one; and while the Journal of American Academy of Dermatology is the international gold standard for dermatology journal advertising, its Indian readership is a fraction of IJDVL's, and its advertising rates are calibrated for the North American market.

Planning Your IJDVL Advertising Campaign: A Strategic Perspective

The brands that get the most out of IJDVL magazine advertising are the ones that approach it as a sustained brand-building exercise rather than a one-